Intro Content
Nature Biomedical Engineering
Time matters when moving and growing fast: predicting glioblastoma prognosis and clinical outcome in a patient-specific manner
We developed a microfluidic assay to enumerate and isolate highly proliferative and motile cells from intratumorally heterogenous population of patient-derived glioblastoma cells. In our Nature BME article, we show that the relative abundance of these cells is predictive of clinical outcomes.